SARS CoV 2 Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
Z
Not yet recruiting
  • COVID-19
  • +3 more
    • (no location specified)
    2022-01-17
    Jan 17, 2022
    P
    Not yet recruiting
    • SARS-CoV-2
    • 1 week placebo(Week 1)
    • +5 more
    • Beijing, China
    • +1 more
    2022-01-12
    Jan 12, 2022
    P
    Not yet recruiting
    • SARS-CoV-2
    • Probiotics daily
    • Placebo daily
    • Beijing, China
    • +1 more
    2022-01-12
    Jan 12, 2022
    C
    Completed
    • Severe Acute Respiratory Syndrome
    • +3 more
    • CVnCoV Vaccine
    • Placebo
    • Ghent, Belgium
    • +3 more
    2021-12-22
    Dec 22, 2021
    U
    Active, not recruiting
    • SARS-CoV-2
    • Nasal swab
    • Serum testing
    • Greifswald, Germany
      Greifswald University Medicine
    2021-12-17
    Dec 17, 2021
    M
    Recruiting
    • SARS-CoV-2
    • mRNA-1283
    • +2 more
    • Phoenix, Arizona
    • +12 more
    2022-01-06
    Jan 6, 2022
    S
    Recruiting
    • SARS-CoV-2
    • Sodium Chloride
    • +4 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    2022-01-04
    Jan 4, 2022
    M
    Active, not recruiting
    • SARS-CoV-2
    • mRNA-1273
    • Placebo
    • Banning, California
    • +24 more
    2021-12-16
    Dec 16, 2021
    G
    Recruiting
    • SARS-CoV-2
    • GLS-5310
    • Placebo
    • Seoul, Korea, Republic of
      Korea University Guro Hospital
    2022-01-05
    Jan 5, 2022
    A
    Active, not recruiting
    • COVID-19
    • SARS-CoV-2
    • AZD1222
    • AZD2816
    • Brasilia, Brazil
    • +34 more
    2022-01-05
    Jan 5, 2022
    M
    Active, not recruiting
    • SARS-CoV-2
    • mRNA-1273
    • Placebo
    • Birmingham, Alabama
    • +99 more
    2021-12-18
    Dec 18, 2021
    M
    Recruiting
    • SARS-CoV-2
      • Durham, North Carolina
        IQVIA Call Center for United States and Canada
      2021-12-18
      Dec 18, 2021
      U
      Terminated
      • Pneumonia, Viral
      • SARS-Cov-2
        • Montpellier, France
        • +1 more
        2021-12-01
        Dec 1, 2021
        U
        Completed
        • COVID-19
        • +3 more
        • Hydroxychloroquine Sulfate
        • Ascorbic Acid
        • Los Angeles, California
        • +7 more
        2021-12-14
        Dec 14, 2021
        K
        Completed
        • SARS-CoV-2
        • +4 more
        • Distilled Water
        • +4 more
        • Jeddah, Saudi Arabia
          Alhamra TETAMMAN clinic (PHC)
        2021-12-10
        Dec 10, 2021
        K
        Recruiting
        • Microbiome
        • +4 more
        • This is observational study
        • Seoul, Korea, Republic of
          Koera University Guro Hospital
        2021-12-08
        Dec 8, 2021
        G
        Active, not recruiting
        • SARS-CoV-2
        • Seoul, Korea, Republic of
        • +4 more
        2021-11-25
        Nov 25, 2021
        C
        Active, not recruiting
        • SARS-CoV-2
        • COVID-19
        • Sample collection
        • Birmingham, Alabama
        • +51 more
        2021-12-07
        Dec 7, 2021
        U
        Terminated
        • SARS-CoV-2
        • Bovine Lactoferrin
        • Maltodextrin
        • Lima, Lim, Peru
        • +1 more
        2021-12-01
        Dec 1, 2021
        G
        Active, not recruiting
        • SARS-CoV-2
        • Seoul, Korea, Republic of
          Severance hospital
        2021-11-25
        Nov 25, 2021
        C
        Active, not recruiting
        • Coronavirus
        • +3 more
        • CVnCoV 6 μg
        • +4 more
        • Panama city, Panama
        • +1 more
        2021-12-06
        Dec 6, 2021
        W
        Withdrawn
        • SARS-CoV-2
        • Covid-19
        • Sirolimus 1 MG/ML
        • Placebo
        • Philadelphia, Pennsylvania
          Thomas Jefferson University Hospital
        2021-12-02
        Dec 2, 2021